← All organizations
Highest phase reached
Phase 1
First clinical trial
Nov 5, 2020Last known activity
Nov 5, 2020
Timeline
2010s
- Jun 1, 2015
Intrommune Therapeutics— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04603300Lead sponsorPhase 1Nov 5, 2020
Details
- Founded
- New York, NY, US Jun 1, 2015
- Last known activity
- Nov 5, 2020